To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C20orf27TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
430 supporting clones for gene C20orf27 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI520569 brain, medulla .a 1 to 856 1 to 748 V198N P199R T200H S201H S202G tiling clone, Suspected internal deletion 748/749
(99 %)
16 diff
(97.9 %id)
TI_43963768   .a 1 to 856 91 to 838 V198N P199R T200H S201H S202G   Suspected internal deletion 748/839
(89 %)
22 diff
(97.4 %id)
NM_001039140.1   .b 1 to 1375 2 to 1376 exact RefSeq,   1376/1376
(100 %)
0 diff
(100 %id)
BM851162 stomach .b 54 to 453 1 to 400   tiling clone,   400/400
(100 %)
5 diff
(98.8 %id)
DB126058 thymus .b 62 to 618 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB126199 thymus .b 62 to 532 2 to 474   capped   473/473
(100 %)
2 diff
(99.6 %id)
BP210954 cerebellum .b 70 to 647 1 to 578       578/578
(100 %)
0 diff
(100 %id)
CX754270 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 76 to 760 1 to 682     Submitted on the opposite strand 682/806
(84 %)
16 diff
(98.1 %id)
BQ962908 leiomyosarcoma, uterus .b 77 to 718 1 to 648       648/785
(82 %)
9 diff
(98.9 %id)
AW663122 2 pooled high-grade transitional celltumors, genitourinary tract .b 79 to 306 10 to 241       232/272
(85 %)
12 diff
(95.6 %id)
BG471090 eye, retinoblastoma .b 80 to 902 1 to 826 F42L G45R H46P D47R A48C ...     826/830
(99 %)
27 diff
(96.8 %id)
BG474804 eye, retinoblastoma .b 80 to 925 1 to 848 M166N D167G R168P H169A H170P ...     848/851
(99 %)
25 diff
(97.1 %id)
CR597474 Neuroblastoma Cot 25-normalized .b 107 to 1353 1 to 1247 exact     1247/1247
(100 %)
0 diff
(100 %id)
CR615129 Neuroblastoma Cot 10-normalized .b 107 to 1375 1 to 1269 exact tiling clone,   1269/1269
(100 %)
0 diff
(100 %id)
BX374670 Neuroblastoma Cot 10-normalized .b 107 to 852 1 to 748 A44P Y133F A135X D194X W195L ... fully sequenced,   748/748
(100 %)
4 diff
(99.5 %id)
AL525575 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 107 to 1077 1 to 956 A44Q G45A H46T D47M A48Q ...     956/1001
(95 %)
17 diff
(98.4 %id)
BX364461 Neuroblastoma Cot 25-normalized .b 107 to 998 1 to 880 A44P     880/970
(90 %)
18 diff
(98.2 %id)
BX350822 Neuroblastoma Cot 10-normalized .b 822 to 1375 557 to 1   fully sequenced,   557/557
(100 %)
8 diff
(98.6 %id)
BU844611 ovary, teratocarcinoma, cell line .c 1 to 823 13 to 842   available from MGC,   830/906
(91 %)
29 diff
(96.8 %id)
BC069204 Ovary, teratocarcinoma .c 2 to 1733 1 to 1732 exact tiling clone, available from MGC, AAA   1732/1732
(100 %)
2 diff
(99.9 %id)
BF436679 fibrotheoma, ovary .c 11 to 550 1 to 542     Submitted on the opposite strand 542/542
(100 %)
5 diff
(99.1 %id)
BF436680 fibrotheoma, ovary .c 11 to 415 1 to 405     Submitted on the opposite strand 405/405
(100 %)
0 diff
(100 %id)
DA064064 cerebellum .c 39 to 482 2 to 445   capped   444/444
(100 %)
0 diff
(100 %id)
BX420192 brain, fetal brain .c 572 to 1527 1 to 941 A18S A19Q G20A H21T D22M ...     941/992
(94 %)
31 diff
(96.9 %id)
BI772519 pooled lung and spleen .c 573 to 1240 1 to 671 A2C A3S A4Q N5A K6R ...     671/673
(99 %)
14 diff
(98.0 %id)
TI_57178964   .c 573 to 1240 30 to 700 A2C A3S A4Q N5A K6R ...     672/702
(95 %)
16 diff
(97.8 %id)
T99954 liver and spleen .c 575 to 962 1 to 390       390/421
(92 %)
15 diff
(96.5 %id)
BQ222095 epithelioid carcinoma, Pancreas .c 590 to 1295 1 to 706 exact     706/710
(99 %)
8 diff
(98.9 %id)
BM009695 amelanotic melanoma, cell line, skin .c 623 to 1282 12 to 670 exact     659/670
(98 %)
14 diff
(98.0 %id)
BM010349 amelanotic melanoma, cell line, skin .c 623 to 1281 12 to 670 exact     659/670
(98 %)
6 diff
(99.2 %id)
TI_59384464   .c 623 to 1282 75 to 733 exact     659/669
(98 %)
13 diff
(98.1 %id)
TI_59385161   .c 623 to 1281 102 to 760 exact     659/669
(98 %)
6 diff
(99.2 %id)
BM691185 eye, RPE and Choroid .c 646 to 1278 1 to 631 exact     631/636
(99 %)
6 diff
(99.1 %id)
BG744337 blood, natural killer cells, cell line .c 650 to 991 1 to 342   fully sequenced,   342/342
(100 %)
1 diff
(99.8 %id)
CF128504 Chondrosarcoma Lung Metastasis cell lines, lung .c 652 to 1292 1 to 642 A4V     642/642
(100 %)
3 diff
(99.6 %id)
TI_154194402   .c 652 to 1340 48 to 736 A4V     689/1047
(65 %)
18 diff
(98.3 %id)
BE259536 brain, neuroblastoma .c 658 to 1264 1 to 614 G25W S26I H27P S28Q H29P ...     614/627
(97 %)
31 diff
(95.1 %id)
AW961032   .c 660 to 1288 1 to 630 exact     630/635
(99 %)
2 diff
(99.7 %id)
CV023125 mixed .c 660 to 1183 1 to 524       524/594
(88 %)
1 diff
(99.9 %id)
AL563446 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 677 to 1689 1004 to 1       1004/1004
(100 %)
32 diff
(96.9 %id)
AW375519 colon .c 678 to 1257 582 to 3       580/583
(99 %)
1 diff
(99.9 %id)
AL525526 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 679 to 1705 1027 to 1       1027/1119
(91 %)
13 diff
(98.9 %id)
BX364460 Neuroblastoma Cot 25-normalized .c 684 to 1702 1024 to 8       1017/1027
(99 %)
33 diff
(96.8 %id)
BF087384 head_neck .c 693 to 1161 482 to 15       468/482
(97 %)
0 diff
(100 %id)
BE798089 lung, small cell carcinoma .c 697 to 1478 27 to 798       772/1008
(76 %)
21 diff
(98.0 %id)
BQ690009 ductal carcinoma, cell line, Pancreas .c 698 to 1299 1 to 601       601/605
(99 %)
5 diff
(99.2 %id)
BI084375 epidermoid carcinoma, cell line, salivary gland .c 700 to 1247 1 to 547   fully sequenced,   547/547
(100 %)
3 diff
(99.5 %id)
BE702984 nervous_normal .c 704 to 1092 1 to 389       389/389
(100 %)
5 diff
(98.8 %id)
BE794106 lung, small cell carcinoma .c 715 to 1354 1 to 636       636/638
(99 %)
7 diff
(99.0 %id)
BU170127 large cell carcinoma, lung .c 717 to 1299 12 to 592       581/596
(97 %)
12 diff
(98.0 %id)
CB128891 Liver .c 722 to 1274 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
BX385682 Neuroblastoma Cot 25-normalized .c 723 to 1704 983 to 1       983/983
(100 %)
6 diff
(99.4 %id)
TI_154194087   .c 738 to 1379 52 to 693       642/982
(65 %)
17 diff
(98.3 %id)
BI161398 epithelioid carcinoma cell line, Pancreas .c 751 to 1455 1 to 726       658/727
(90 %)
17 diff
(97.7 %id)
AA036978 uterus .c 768 to 1145 1 to 384       384/406
(94 %)
17 diff
(95.9 %id)
BF836264 head_neck .c 803 to 1363 563 to 5     Submitted on the opposite strand 559/563
(99 %)
1 diff
(99.9 %id)
BX334205 Neuroblastoma Cot 50-normalized .c 826 to 1706 892 to 1       892/892
(100 %)
63 diff
(93.0 %id)
BX361826   .c 846 to 1678 869 to 37   AAA   833/853
(97 %)
42 diff
(95.1 %id)
BF237461 leiomyosarcoma cell line, uterus .c 859 to 1365 1 to 507       507/509
(99 %)
2 diff
(99.7 %id)
BM794316 Ascites, stomach .c 873 to 1299 1 to 427       427/427
(100 %)
0 diff
(100 %id)
CF128241 Chondrosarcoma Lung Metastasis cell lines, lung .c 885 to 1298 1 to 414       414/414
(100 %)
0 diff
(100 %id)
CR623724 fetal liver .c 887 to 1734 1 to 848   tiling clone,   848/848
(100 %)
0 diff
(100 %id)
AL532418 brain, fetal liver, Liver, neuroblastoma cells .c 887 to 1730 1 to 842   fully sequenced,   842/842
(100 %)
8 diff
(99.1 %id)
AI375009   .c 911 to 1294 453 to 70       384/453
(84 %)
1 diff
(99.8 %id)
BG744905 blood, natural killer cells, cell line .c 930 to 1671 755 to 16   fully sequenced,   740/755
(98 %)
0 diff
(100 %id)
CD674785 eye, lens .c 932 to 1293 1 to 362       362/362
(100 %)
0 diff
(100 %id)
AA058761 uterus .c 951 to 1447 1 to 495       495/496
(99 %)
4 diff
(99.2 %id)
BX375887 Neuroblastoma Cot 25-normalized .c 953 to 1709 763 to 1       763/846
(90 %)
53 diff
(93.8 %id)
CB161095 Liver .c 961 to 1295 1 to 335       335/335
(100 %)
0 diff
(100 %id)
TI_149300383   .c 961 to 1733 873 to 108   AAA   766/951
(80 %)
29 diff
(97.0 %id)
BM743189 stomach .c 966 to 1471 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
BG391258 embryonal carcinoma, cell line, testis .c 969 to 1734 1 to 762       762/777
(98 %)
26 diff
(96.7 %id)
BQ689101 ductal carcinoma, cell line, Pancreas .c 978 to 1734 768 to 9     Submitted on the opposite strand 760/1002
(75 %)
19 diff
(98.2 %id)
TI_227714894   .c 982 to 1733 846 to 95   AAA   752/960
(78 %)
9 diff
(99.1 %id)
CD365495 Alveolar Macrophage, lung .c 986 to 1733 766 to 19   AAA   748/750
(99 %)
7 diff
(99.1 %id)
BM927797 hepatocellular carcinoma, cell line, Liver .c 994 to 1295 1 to 302       302/302
(100 %)
0 diff
(100 %id)
AL532417 brain, fetal liver, Liver, neuroblastoma cells .c 1007 to 1703 700 to 2   fully sequenced,   699/700
(99 %)
1 diff
(99.9 %id)
BU856502 ovary, teratocarcinoma, cell line .c 1010 to 1302 1 to 293       293/293
(100 %)
0 diff
(100 %id)
EC493992 Prostate .c 1016 to 1105 93 to 5       89/93
(95 %)
0 diff
(100 %id)
BE515115 endometrium, adenocarcinoma cell line, uterus .c 1039 to 1619 1 to 615   AAA   528/778
(67 %)
29 diff
(96.3 %id)
EC527215 Prostate .c 1040 to 1127 1 to 88       88/88
(100 %)
0 diff
(100 %id)
BM994637 lung, Metastatic Chondrosarcoma .c 1047 to 1728 698 to 17   AAA   682/682
(100 %)
4 diff
(99.5 %id)
BI084698 epidermoid carcinoma, cell line, salivary gland .c 1217 to 1682 467 to 1   fully sequenced,   467/467
(100 %)
5 diff
(99.0 %id)
R00301 liver and spleen .c 1376 to 1732 359 to 8       352/362
(97 %)
0 diff
(100 %id)
AA036979 uterus .c 1466 to 1729 272 to 5       268/272
(98 %)
0 diff
(100 %id)
BU726531 eye, RPE and Choroid .c 1478 to 1733 273 to 18   AAA   256/256
(100 %)
0 diff
(100 %id)
AK290955   .d 1 to 1441 2 to 1442 exact tiling clone,   1442/1442
(100 %)
2 diff
(99.9 %id)
DA693723   .d 1 to 565 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
CR596792 T cells (Jurkat cell line) Cot10-normalized .d 287 to 1414 3 to 1130 exact     1130/1130
(100 %)
0 diff
(100 %id)
BX362188   .d 287 to 750 3 to 465   fully sequenced,   465/465
(100 %)
1 diff
(99.8 %id)
H38495 brain .d 292 to 750 1 to 460       460/528
(87 %)
16 diff
(97.0 %id)
AA338808 brain .d 372 to 524 1 to 153       153/153
(100 %)
2 diff
(98.7 %id)
TI_1948146126   .d 372 to 795 127 to 554       428/1314
(32 %)
15 diff
(98.9 %id)
TI_1948146769   .d 372 to 796 124 to 549       426/1314
(32 %)
15 diff
(98.9 %id)
AW375527 colon .d 390 to 971 584 to 3       582/584
(99 %)
2 diff
(99.7 %id)
BQ267733 insulinoma, Pancreas .d 392 to 563 1 to 172       172/172
(100 %)
3 diff
(98.3 %id)
T98407 liver and spleen .d 609 to 766 1 to 159       159/159
(100 %)
3 diff
(98.2 %id)
BX362187   .d 720 to 1414 691 to 1   fully sequenced,   691/691
(100 %)
30 diff
(95.7 %id)
T98466 liver and spleen .d 1114 to 1398 297 to 5       293/354
(82 %)
0 diff
(100 %id)
BQ272341 insulinoma, Pancreas .d 1191 to 1329 139 to 1       139/139
(100 %)
0 diff
(100 %id)
AK097645 testis .e 1 to 1879 2 to 1880 exact tiling clone, available from FLJ,   1880/1880
(100 %)
4 diff
(99.8 %id)
DB043380 testis .e 1 to 571 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
BG714548 brain, hypothalamus .e 577 to 1391 1 to 811 A159P E160R L161A E162G Y163I ...     811/812
(99 %)
25 diff
(97.0 %id)
BF978883 melanotic melanoma, high MDR, skin .e 581 to 1284 1 to 702       702/746
(94 %)
12 diff
(98.4 %id)
DB498557 hypothalamus .e 582 to 1082 1 to 501       501/501
(100 %)
0 diff
(100 %id)
DA807453 brain .e 583 to 1135 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CB149255 Liver .e 597 to 1142 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
BP330285 rectum .e 601 to 1181 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP371392 testis .e 601 to 1182 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG333103 large cell carcinoma, lung .e 602 to 1391 1 to 798 T147N P148A M149H L150A L151A ...     798/800
(99 %)
17 diff
(97.9 %id)
BM755494 stomach .e 602 to 798 1 to 196       196/196
(100 %)
6 diff
(97.0 %id)
BG436984 large cell carcinoma, lung .e 605 to 1354 1 to 763 E24A G25R S26I H27P S28Q ...     763/763
(100 %)
33 diff
(95.7 %id)
BP339558 Spleen .e 606 to 1175 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DB475915 hippocampus .e 609 to 1110 1 to 502       502/505
(99 %)
7 diff
(98.7 %id)
BG770842 adenocarcinoma, Prostate .e 610 to 1336 1 to 729 T130H C131L V132C R133A V134R ...     729/730
(99 %)
5 diff
(99.4 %id)
DA617420   .e 610 to 1110 2 to 504   capped   503/503
(100 %)
3 diff
(99.5 %id)
CD384871 embryonic trophoblasts, made from WA01 stemcells .e 611 to 1439 24 to 854 E46G     831/862
(96 %)
13 diff
(98.5 %id)
BP263020 small intestine .e 612 to 1177 1 to 566       566/566
(100 %)
9 diff
(98.5 %id)
CB124248 Liver .e 612 to 1160 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
TI_57221292   .e 613 to 1396 82 to 868 H31T F32L D33M E34R K35S ...     787/894
(88 %)
51 diff
(94.3 %id)
BG829959 epithelioid carcinoma cell line, Pancreas .e 617 to 1346 1 to 738 F57L L58P K59*     738/738
(100 %)
16 diff
(97.9 %id)
BI757853 brain .e 617 to 1396 1 to 783 H31T F32L D33M E34R K35S ...     783/809
(96 %)
46 diff
(94.4 %id)
BI085307 astrocytoma grade IV, cell line, brain .e 619 to 1265 1 to 647   fully sequenced,   647/647
(100 %)
2 diff
(99.7 %id)
BM479991 embryonal carcinoma, cell line, testis .e 619 to 1439 1 to 831 F173L D174*     831/1017
(81 %)
23 diff
(97.8 %id)
BQ420916 large cell carcinoma, lung .e 620 to 1445 1 to 837 G126S C131L V132C R133A V134R ...     837/918
(91 %)
41 diff
(95.6 %id)
BQ896826 epidermoid carcinoma, cell line, lung .e 622 to 1439 1 to 822 exact     822/871
(94 %)
7 diff
(99.2 %id)
BQ924994 epidermoid carcinoma, cell line, lung .e 622 to 1445 1 to 823 exact     823/827
(99 %)
6 diff
(99.3 %id)
BM923850 pooled colon, kidney, stomach .e 623 to 1418 1 to 797 exact     797/812
(98 %)
2 diff
(99.8 %id)
T85508 liver and spleen .e 626 to 968 1 to 347       347/415
(83 %)
23 diff
(94.5 %id)
BF102631 adenocarcinoma, Prostate .e 631 to 990 1 to 360       360/360
(100 %)
0 diff
(100 %id)
CB121529 Liver .e 631 to 1066 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
BP300108   .e 631 to 1213 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BI091623 cervix .e 632 to 1403 1 to 782 G7V N8Q K9Q P10A R11Q ...     782/900
(86 %)
27 diff
(97.0 %id)
AK022713   .e 633 to 1884 948 to 2199 S28G L92P available from FLJ,   1252/2199
(56 %)
10 diff
(99.6 %id)
AI765107 colon, colon tumor, RER+ .e 633 to 1109 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
DA729433   .e 634 to 1344 2 to 710 Q137X K155S C156V V157W G158P ... capped   709/709
(100 %)
17 diff
(97.7 %id)
BM542849 leiomyosarcoma, uterus .e 636 to 1442 1 to 810 D174*     810/1133
(71 %)
11 diff
(99.1 %id)
BM850538 stomach .e 636 to 757 1 to 122       122/122
(100 %)
3 diff
(97.6 %id)
BP340657 Spleen .e 636 to 1214 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BM911524 amelanotic melanoma, cell line, skin .e 637 to 1406 1 to 773 V136E E166Q S168F     773/1154
(66 %)
19 diff
(98.4 %id)
TI_57172912   .e 637 to 1308 55 to 724       670/724
(92 %)
7 diff
(99.1 %id)
AL583482 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 641 to 1003 1 to 362   fully sequenced,   362/362
(100 %)
6 diff
(98.4 %id)
BM460806 leiomyosarcoma, uterus .e 642 to 1398 25 to 785 exact     761/1125
(67 %)
17 diff
(98.5 %id)
BU538462 adenocarcinoma, cell line, breast .e 642 to 1445 1 to 800 exact     800/808
(99 %)
13 diff
(98.4 %id)
BU846349 ovary, teratocarcinoma, cell line .e 642 to 1402 29 to 805 K6D S50G F68V K117E E118R ...     777/1013
(76 %)
53 diff
(94.8 %id)
BU859537 ovary, teratocarcinoma, cell line .e 642 to 1436 36 to 834 E166K     799/945
(84 %)
18 diff
(98.1 %id)
CX164128 human embryonic stem cells differentiated toan early endodermal cell type .e 642 to 1430 1 to 789 exact     789/789
(100 %)
0 diff
(100 %id)
AK000557   .e 643 to 1879 1 to 1237 S14G available from FLJ, AAA   1237/1237
(100 %)
2 diff
(99.9 %id)
AK024220   .e 643 to 1883 1 to 1241 exact tiling clone, available from FLJ,   1241/1241
(100 %)
0 diff
(100 %id)
AK225109 coronary artery .e 643 to 1863 1 to 1221 K6E     1221/1221
(100 %)
3 diff
(99.8 %id)
BP207833 coronary artery .e 643 to 1226 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP211982 cerebrum .e 643 to 1225 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP212413 cerebrum .e 643 to 1212 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
CN427501 embryonic stem cells, DMSO-treated H9 cellline .e 643 to 1265 1 to 623       623/623
(100 %)
6 diff
(99.1 %id)
BP260532 small intestine .e 643 to 1226 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP261364 small intestine .e 643 to 1210 1 to 568       568/568
(100 %)
3 diff
(99.5 %id)
BM545633 ovary (pool of 3) .e 643 to 1392 1 to 761 A159R E160P L161S E162W Y163N ...     761/1043
(72 %)
18 diff
(98.3 %id)
BP273995   .e 643 to 1200 1 to 558       558/558
(100 %)
4 diff
(99.3 %id)
CB119147 Liver .e 643 to 996 1 to 354       354/354
(100 %)
3 diff
(99.2 %id)
CB113552 Liver .e 643 to 928 1 to 286       286/286
(100 %)
4 diff
(98.7 %id)
CB138769 Liver .e 643 to 807 1 to 165       165/165
(100 %)
0 diff
(100 %id)
BP308395 brain .e 643 to 1234 1 to 592       592/599
(98 %)
4 diff
(99.4 %id)
BP309407 brain .e 643 to 1225 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BM835654 stomach .e 643 to 1145 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
DA003064   .e 644 to 1211 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA006638   .e 644 to 1210 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA094290 cerebellum .e 644 to 1207 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA193383 amygdala .e 644 to 1247 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
DA203155 brain .e 644 to 1027 2 to 387   capped   386/386
(100 %)
3 diff
(99.3 %id)
DA334792 hippocampus .e 644 to 1202 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA402306 thalamus .e 644 to 1163 2 to 522   capped   521/521
(100 %)
1 diff
(99.9 %id)
DA432021 colon .e 644 to 1110 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
BF312602 brain, neuroblastoma .e 644 to 1520 1 to 871 exact     871/948
(91 %)
45 diff
(95.3 %id)
BF315852 brain, neuroblastoma .e 644 to 1068 1 to 428       428/428
(100 %)
4 diff
(99.1 %id)
BF689773 melanotic melanoma, high MDR (cell line), skin .e 644 to 1201 1 to 558   fully sequenced,   558/558
(100 %)
1 diff
(99.9 %id)
BG777388 adenocarcinoma, Prostate .e 644 to 1282 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
BU845592 ovary, teratocarcinoma, cell line .e 644 to 1424 1 to 781 exact     781/788
(99 %)
1 diff
(99.9 %id)
BU846026 ovary, teratocarcinoma, cell line .e 644 to 1438 1 to 800 M149L     800/936
(85 %)
14 diff
(98.6 %id)
DA604555   .e 644 to 1160 2 to 519   capped   518/518
(100 %)
2 diff
(99.7 %id)
DA614838   .e 644 to 1206 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
AU123303   .e 644 to 1166 2 to 524   capped   523/523
(100 %)
6 diff
(98.9 %id)
DA890851 rectum .e 644 to 1106 2 to 465   capped   464/471
(98 %)
5 diff
(99.0 %id)
BC024036 Brain, neuroblastoma .e 645 to 1883 1 to 1239 exact available from MGC, AAA   1239/1239
(100 %)
2 diff
(99.9 %id)
CB149846 Liver .e 645 to 1025 1 to 380       380/380
(100 %)
3 diff
(99.3 %id)
BM835254 stomach .e 645 to 1206 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DA898699 skeletal muscle .e 645 to 1208 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BP375937 uterus .e 645 to 1222 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DA358443 subthalamic nucleus .e 646 to 1203 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
CR614738 Neuroblastoma Cot 10-normalized .e 646 to 1854 1 to 1209 exact     1209/1209
(100 %)
0 diff
(100 %id)
BI222570 cervical carcinoma cell line, cervix .e 646 to 1240 1 to 599       599/616
(97 %)
12 diff
(98.1 %id)
BI223583 cervical carcinoma cell line, cervix .e 646 to 1347 1 to 711 G7V N8Q K9Q P10A R11Q ...     711/711
(100 %)
10 diff
(98.6 %id)
BG713937 brain, hypothalamus .e 647 to 1355 1 to 708 exact     708/709
(99 %)
10 diff
(98.6 %id)
BI828061 brain, medulla .e 647 to 1308 1 to 661       661/661
(100 %)
2 diff
(99.7 %id)
BQ717450 sympathetic trunk .e 647 to 1379 24 to 767 R143G H144T H145T G146A T147R ...     744/1003
(74 %)
32 diff
(96.9 %id)
BQ706450 Spleen .e 648 to 973 1 to 327       327/1001
(32 %)
6 diff
(99.5 %id)
BU543599 carcinoma, cell line, Prostate .e 648 to 1445 87 to 884 exact     798/908
(87 %)
16 diff
(98.3 %id)
BM920323 pooled pancreas and spleen .e 649 to 1448 1 to 803 exact     803/1066
(75 %)
5 diff
(99.6 %id)
DA252401 caudate nucleus .e 650 to 1226 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AW250662 lung, small cell carcinoma .e 651 to 1033 5 to 387       383/407
(94 %)
10 diff
(97.6 %id)
DT217546 brain .e 652 to 1332 1 to 681       681/681
(100 %)
0 diff
(100 %id)
DB491847 hypothalamus .e 652 to 912 1 to 262       260/262
(99 %)
3 diff
(98.9 %id)
DB493852 hypothalamus .e 652 to 1160 1 to 509       509/509
(100 %)
0 diff
(100 %id)
DB495147 hypothalamus .e 652 to 1141 1 to 490       490/490
(100 %)
0 diff
(100 %id)
CB110568 Liver .e 652 to 1244 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
BP330296 rectum .e 652 to 1233 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM821179 stomach .e 652 to 1032 1 to 381       381/381
(100 %)
0 diff
(100 %id)
BM839758 stomach .e 652 to 1281 1 to 630       630/630
(100 %)
0 diff
(100 %id)
DA728995   .e 653 to 1303 2 to 651   capped   650/650
(100 %)
1 diff
(99.9 %id)
BM910105 astrocytoma grade IV, cell line, brain .e 654 to 1085 1 to 435       435/1142
(38 %)
5 diff
(99.6 %id)
BC012196 Lung, small cell carcinoma .e 656 to 1884 1 to 1229 exact available from MGC, AAA   1229/1229
(100 %)
3 diff
(99.8 %id)
CN427503 embryonic stem cells, cell lines H1, H7, andH9 .e 656 to 1343 1 to 690 exact     690/690
(100 %)
3 diff
(99.6 %id)
BG745235 Spleen .e 656 to 1234 1 to 580   fully sequenced,   580/580
(100 %)
7 diff
(98.8 %id)
BG821747 adenocarcinoma cell line, colon .e 656 to 1378 1 to 720 exact     720/730
(98 %)
8 diff
(99.0 %id)
BM544848 ovary (pool of 3) .e 656 to 1439 21 to 804 exact     784/810
(96 %)
6 diff
(99.3 %id)
CN427504 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 657 to 1161 1 to 505       505/505
(100 %)
3 diff
(99.5 %id)
AW631125 2 pooled high-grade transitional celltumors, genitourinary tract .e 657 to 1063 1 to 407       407/407
(100 %)
0 diff
(100 %id)
AW404558 lymph .e 657 to 867 8 to 217       210/217
(96 %)
6 diff
(97.3 %id)
BG397156 melanotic melanoma, skin .e 657 to 1335 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
BG468438 adenocarcinoma cell line, colon .e 657 to 1390 1 to 732 F173V D174*     732/733
(99 %)
7 diff
(99.1 %id)
BI195525 brain, neuroblastoma .e 657 to 1281 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BI197666 brain, neuroblastoma .e 657 to 1348 1 to 695 H144P Y163I D164R S165L E166K ...     695/695
(100 %)
7 diff
(99.0 %id)
BM563097 brain, medulla .e 657 to 1434 1 to 779 exact     779/783
(99 %)
4 diff
(99.5 %id)
BQ052519 blood, natural killer cells, cell line .e 657 to 1445 1 to 788 exact     788/792
(99 %)
7 diff
(99.2 %id)
BU845574 ovary, teratocarcinoma, cell line .e 657 to 1453 1 to 797 Q137X     797/801
(99 %)
9 diff
(98.9 %id)
TI_154141530   .e 657 to 1149 81 to 572       492/492
(100 %)
5 diff
(99.0 %id)
BG286915 bladder, transitional cell papilloma, cell line .e 658 to 1356 1 to 698 H145T T147R M149C L150C L151W ...     698/922
(75 %)
13 diff
(98.6 %id)
BG283634 adenocarcinoma, cell line, Prostate .e 658 to 1416 1 to 766 G25R S26I H27P S28T H29A ...     766/947
(80 %)
31 diff
(96.8 %id)
BQ053113 blood, natural killer cells, cell line .e 658 to 1450 1 to 788 E166K     788/792
(99 %)
13 diff
(98.4 %id)
BG117486 adenocarcinoma, cell line, Liver .e 659 to 1313 1 to 652       652/963
(67 %)
9 diff
(99.1 %id)
BQ441156 melanotic melanoma, skin .e 659 to 1447 1 to 787 exact     787/857
(91 %)
6 diff
(99.3 %id)
BP428506   .e 659 to 996 1 to 338       338/338
(100 %)
4 diff
(98.9 %id)
BG751475 eye, normal pigmented retinal epithelium .e 660 to 1445 1 to 780 exact     780/885
(88 %)
11 diff
(98.8 %id)
BM020304 astrocytoma grade IV, cell line, brain .e 661 to 1438 1 to 769 V136G Q137A A138G R139P V140R ...     769/770
(99 %)
22 diff
(97.2 %id)
BM555778 duodenal adenocarcinoma, cell line, small intestine .e 661 to 1455 1 to 791 exact     791/1027
(77 %)
8 diff
(99.3 %id)
BQ955008 sciatic nerve .e 661 to 1448 1 to 786 Q137X     786/791
(99 %)
7 diff
(99.2 %id)
BU856133 ovary, teratocarcinoma, cell line .e 661 to 1442 35 to 821 E160R L161A E162G Y163I D164R ...     787/961
(81 %)
15 diff
(98.5 %id)
BG474219 eye, retinoblastoma .e 662 to 1236 1 to 573       573/573
(100 %)
3 diff
(99.5 %id)
BM562759 astrocytoma grade IV, cell line, brain .e 662 to 1448 1 to 781 H167Y     781/1085
(71 %)
8 diff
(99.3 %id)
BU159019 epithelioid carcinoma, Pancreas .e 662 to 1445 1 to 783 D174*     783/787
(99 %)
11 diff
(98.7 %id)
BU164602 epithelioid carcinoma, Pancreas .e 662 to 1446 1 to 796 W170R H171A G172P F173L D174*     796/911
(87 %)
22 diff
(97.6 %id)
TI_59391088   .e 662 to 1438 126 to 893 V136G Q137A A138G R139P V140R ...     768/769
(99 %)
21 diff
(97.3 %id)
DN990652 brain, whole brain .e 663 to 1324 8 to 670       663/670
(98 %)
7 diff
(99.0 %id)
CF127904 Chondrosarcoma Lung Metastasis cell lines, lung .e 665 to 1335 1 to 671 exact     671/671
(100 %)
0 diff
(100 %id)
BM786768 stomach .e 665 to 1324 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
TI_154193595   .e 665 to 1447 51 to 832 exact     782/1028
(76 %)
7 diff
(99.4 %id)
CD674340 eye, lens .e 666 to 1108 1 to 443       443/443
(100 %)
0 diff
(100 %id)
TI_57220975   .e 667 to 1393 53 to 777 exact     725/777
(93 %)
12 diff
(98.5 %id)
BQ440468 eye, retinoblastoma .e 668 to 1400 1 to 744 M149X L151A D152G G153W V154W ...     744/972
(76 %)
14 diff
(98.6 %id)
AI474992 anaplastic oligodendroglioma, brain .e 669 to 942 1 to 274     Submitted on the opposite strand 274/274
(100 %)
1 diff
(99.7 %id)
CD519561 White Matter .e 669 to 1449 1 to 785 exact     785/911
(86 %)
17 diff
(98.2 %id)
CN427506 embryonic stem cells, DMSO-treated H9 cellline .e 672 to 1233 1 to 562       562/562
(100 %)
0 diff
(100 %id)
CR991547 T-Lymphocytes .e 672 to 1435 1 to 764 exact     764/764
(100 %)
0 diff
(100 %id)
BX385683 Neuroblastoma Cot 25-normalized .e 674 to 1590 1 to 917 A19P     917/917
(100 %)
4 diff
(99.6 %id)
BE795641 lung, small cell carcinoma .e 675 to 1462 1 to 787 exact     787/1001
(78 %)
17 diff
(98.4 %id)
BG438186 large cell carcinoma, lung .e 675 to 1356 1 to 682 E100D G101R Y102L S103*     682/683
(99 %)
5 diff
(99.3 %id)
BI756146 brain .e 675 to 1393 1 to 717 exact     717/717
(100 %)
7 diff
(99.1 %id)
CR591203 Neuroblastoma Cot 25-normalized .e 677 to 1860 1 to 1184 exact     1184/1184
(100 %)
0 diff
(100 %id)
BE786533 large cell carcinoma, lung .e 678 to 1356 1 to 725 R13L S14E I15Y R16P F17L ...     546/726
(75 %)
32 diff
(95.6 %id)
BE779165 eye, retinoblastoma .e 679 to 1107 1 to 429       429/429
(100 %)
0 diff
(100 %id)
BE793892 lung, small cell carcinoma .e 679 to 1491 1 to 801 E82R A83G P84T V85C S87Q ...     801/887
(90 %)
32 diff
(96.4 %id)
BM919634 pooled pancreas and spleen .e 679 to 1429 18 to 769 exact     752/811
(92 %)
10 diff
(98.8 %id)
BE536848 cervix .e 682 to 1171 1 to 509       509/887
(57 %)
32 diff
(96.4 %id)
CN427502 embryonic stem cells, DMSO-treated H9 cellline .e 683 to 1238 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BU183373 melanotic melanoma, cell line, skin .e 685 to 1445 15 to 778 exact     764/966
(79 %)
16 diff
(98.4 %id)
CR592157 Neuroblastoma Cot 50-normalized .e 689 to 1854 1 to 1166 exact     1166/1166
(100 %)
0 diff
(100 %id)
CR597067 Neuroblastoma Cot 50-normalized .e 689 to 1840 1 to 1152 exact     1152/1152
(100 %)
0 diff
(100 %id)
CR599225 Neuroblastoma Cot 25-normalized .e 689 to 1853 1 to 1165 exact     1165/1165
(100 %)
0 diff
(100 %id)
CR606948 B cells (Ramos cell line) Cot 25-normalized .e 689 to 1850 1 to 1162 exact     1162/1162
(100 %)
0 diff
(100 %id)
CR614642 Neuroblastoma Cot 10-normalized .e 689 to 1865 1 to 1177 exact     1177/1177
(100 %)
0 diff
(100 %id)
CR616702 Placenta Cot 25-normalized .e 689 to 1854 1 to 1166 exact     1166/1166
(100 %)
0 diff
(100 %id)
CR626675 Neuroblastoma Cot 25-normalized .e 689 to 1854 1 to 1166 exact     1166/1166
(100 %)
0 diff
(100 %id)
AL519665 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 689 to 1142 1 to 454   fully sequenced,   454/454
(100 %)
0 diff
(100 %id)
AL523402 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 689 to 1526 1 to 829 A19X L88X V134D T135D V136G ... fully sequenced,   829/829
(100 %)
1 diff
(99.9 %id)
AL526667 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 689 to 1142 1 to 454   fully sequenced,   454/454
(100 %)
0 diff
(100 %id)
AL527270 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 689 to 1142 1 to 453   fully sequenced,   453/453
(100 %)
2 diff
(99.6 %id)
AL529455 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 689 to 1682 1 to 986 exact     986/1034
(95 %)
11 diff
(99.0 %id)
BX403183 Neuroblastoma Cot 50-normalized .e 689 to 1298 1 to 610   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 610/853
(71 %)
24 diff
(97.2 %id)
AL530298 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 689 to 1721 1 to 1025 A19Q G20A H21T D22M A23Q ...     1025/1102
(93 %)
28 diff
(97.5 %id)
BX461294 brain, fetal brain .e 689 to 1553 1 to 848 A19X     848/939
(90 %)
23 diff
(97.6 %id)
AL544288 placenta, Placenta Cot 25-normalized .e 689 to 1188 1 to 499   fully sequenced,   499/499
(100 %)
1 diff
(99.8 %id)
BX365747   .e 689 to 1794 1 to 1097 A19T Y108F     1097/1106
(99 %)
25 diff
(97.8 %id)
BU191133 melanotic melanoma, cell line, skin .e 695 to 1428 24 to 753 D164H     730/1001
(72 %)
16 diff
(98.5 %id)
BU179565 melanotic melanoma, cell line, skin .e 699 to 1442 1 to 746 exact     746/750
(99 %)
6 diff
(99.2 %id)
BU151594 melanotic melanoma, cell line, skin .e 699 to 1450 1 to 751 exact     751/756
(99 %)
5 diff
(99.4 %id)
BQ892717 melanotic melanoma, cell line, skin .e 699 to 1447 1 to 747 exact     747/752
(99 %)
9 diff
(98.9 %id)
BQ679179 melanotic melanoma, cell line, skin .e 699 to 1447 1 to 750 exact     750/907
(82 %)
8 diff
(99.2 %id)
BU168654 melanotic melanoma, cell line, skin .e 699 to 1442 1 to 749 exact     749/875
(85 %)
8 diff
(99.1 %id)
BU158029 melanotic melanoma, cell line, skin .e 699 to 1434 1 to 738 exact     738/958
(77 %)
12 diff
(98.8 %id)
BQ680115 melanotic melanoma, cell line, skin .e 699 to 1414 1 to 716 exact     716/960
(74 %)
12 diff
(98.8 %id)
BQ678751 melanotic melanoma, cell line, skin .e 699 to 1429 1 to 732 exact     732/919
(79 %)
15 diff
(98.4 %id)
BQ683134 melanotic melanoma, cell line, skin .e 699 to 1401 1 to 707 H171D     707/845
(83 %)
8 diff
(99.1 %id)
BQ677942 melanotic melanoma, cell line, skin .e 699 to 1402 1 to 709 F173X D174*     709/920
(77 %)
9 diff
(99.1 %id)
BQ680777 melanotic melanoma, cell line, skin .e 699 to 1402 1 to 706 exact     706/876
(80 %)
15 diff
(98.3 %id)
BU157473 melanotic melanoma, cell line, skin .e 699 to 1439 1 to 745 E166K     745/926
(80 %)
17 diff
(98.2 %id)
BQ675975 melanotic melanoma, cell line, skin .e 699 to 1392 1 to 700 Q137H E160Q D169H F173L D174*     700/1018
(68 %)
16 diff
(98.5 %id)
CD519337 White Matter .e 701 to 1447 1 to 749 exact     749/752
(99 %)
6 diff
(99.3 %id)
CB270311 adipose .e 717 to 1185 1 to 470       470/470
(100 %)
8 diff
(98.3 %id)
BI088772 cervix .e 719 to 1444 1 to 722 D169R W170L H171G G172T F173A ...     722/722
(100 %)
11 diff
(98.5 %id)
AL520518 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 942 to 1854 909 to 1   fully sequenced,   909/909
(100 %)
7 diff
(99.3 %id)
AL561804 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 1081 to 1865 790 to 1   fully sequenced,   790/790
(100 %)
19 diff
(97.6 %id)
AL562725 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1081 to 1854 778 to 1   fully sequenced,   778/778
(100 %)
8 diff
(99.0 %id)
AL527447 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1081 to 1853 773 to 1   fully sequenced,   773/773
(100 %)
5 diff
(99.4 %id)
AL544266 placenta, Placenta Cot 25-normalized .e 1158 to 1854 700 to 1   fully sequenced,   700/700
(100 %)
10 diff
(98.6 %id)
BF690313 melanotic melanoma, high MDR (cell line), skin .e 1171 to 1843 689 to 18   fully sequenced,   672/689
(97 %)
0 diff
(100 %id)
BG746103 Spleen .e 1204 to 1830 638 to 3   fully sequenced,   636/638
(99 %)
1 diff
(99.9 %id)
BI085955 astrocytoma grade IV, cell line, brain .e 1235 to 1830 618 to 3   fully sequenced,   616/618
(99 %)
0 diff
(100 %id)
DB338021 testis .e 1364 to 1879 516 to 1       516/516
(100 %)
1 diff
(99.9 %id)
AW246799 lung, small cell carcinoma .e 1459 to 1884 436 to 11   AAA   426/426
(100 %)
10 diff
(97.7 %id)
T85297 liver and spleen .e 1467 to 1885 430 to 5   tiling clone,   426/431
(98 %)
0 diff
(100 %id)
AL523401 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1496 to 1848 353 to 1   fully sequenced,   353/353
(100 %)
13 diff
(96.4 %id)
DB354037   .e 1555 to 1881 326 to 1       326/328
(99 %)
4 diff
(98.8 %id)
AW630338 2 pooled high-grade transitional celltumors, genitourinary tract .e 1639 to 1885 254 to 8       247/254
(97 %)
0 diff
(100 %id)
DA305847 hippocampus .f 1 to 567 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
DA532396 brain .f 1 to 502 2 to 499   capped   498/498
(100 %)
2 diff
(99.6 %id)
DA236509 brain .f 10 to 599 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA809957 brain .f 10 to 534 2 to 527   tiling clone, capped   526/526
(100 %)
1 diff
(99.9 %id)
AK125202 brain .f 434 to 2892 1 to 2459 exact tiling clone, available from FLJ,   2459/2459
(100 %)
3 diff
(99.9 %id)
DA528455 brain .f 435 to 1042 2 to 609   capped   608/608
(100 %)
0 diff
(100 %id)
TI_149309118   .f 2232 to 2882 760 to 110   AAA   651/922
(70 %)
3 diff
(99.7 %id)
TI_154124550   .f 2232 to 2885 780 to 122       659/991
(66 %)
0 diff
(100 %id)
BM824268 Ascites, stomach .f 2241 to 2406 1 to 166       166/166
(100 %)
1 diff
(99.4 %id)
BE394031 endometrium, adenocarcinoma cell line, uterus .f 2259 to 2753 1 to 497       497/497
(100 %)
4 diff
(99.2 %id)
CR620256 neuroblastoma .f 2267 to 2882 1 to 616       616/616
(100 %)
0 diff
(100 %id)
AL517000 brain, neuroblastoma, neuroblastoma cells .f 2267 to 2882 1 to 616       616/616
(100 %)
12 diff
(98.1 %id)
AA366003 Pancreas .f 2268 to 2562 1 to 295       295/295
(100 %)
1 diff
(99.7 %id)
BM998219 lung, Metastatic Chondrosarcoma .f 2291 to 2882 610 to 19   AAA   592/592
(100 %)
5 diff
(99.2 %id)
BG779766 adenocarcinoma, Prostate .f 2298 to 2862 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
BI869571 adenocarcinoma, cell line, Liver .f 2303 to 2887 1 to 585   AAA   585/585
(100 %)
5 diff
(99.2 %id)
TI_57229034   .f 2303 to 2882 83 to 662   AAA   580/580
(100 %)
2 diff
(99.7 %id)
BU856029 ovary, teratocarcinoma, cell line .f 2332 to 2883 576 to 20     Submitted on the opposite strand 557/1009
(55 %)
0 diff
(100 %id)
AI761506 colon, colon tumor, RER+ .f 2345 to 2882 539 to 1       539/544
(99 %)
6 diff
(98.9 %id)
CR598944 Neuroblastoma Cot 50-normalized .f 2346 to 2900 1 to 555   tiling clone,   555/555
(100 %)
0 diff
(100 %id)
BX395194 Neuroblastoma Cot 50-normalized .f 2346 to 2883 1 to 541   fully sequenced,   541/541
(100 %)
13 diff
(97.6 %id)
BX355285 Neuroblastoma Cot 50-normalized .f 2346 to 2883 1 to 537   fully sequenced,   537/537
(100 %)
4 diff
(99.3 %id)
DB569625 hypothalamus .f 2363 to 2882 1 to 519     Submitted on the opposite strand 519/519
(100 %)
7 diff
(98.7 %id)
DB317576 brain .f 2365 to 2892 528 to 1       528/528
(100 %)
5 diff
(99.1 %id)
BP396136 pancreatic islet .f 2376 to 2883 1 to 508     Submitted on the opposite strand 508/511
(99 %)
3 diff
(99.5 %id)
AI573291 anaplastic oligodendroglioma, brain .f 2390 to 2877 488 to 1       488/488
(100 %)
4 diff
(99.2 %id)
AI744657 pooled .f 2395 to 2883 490 to 2       489/490
(99 %)
0 diff
(100 %id)
AA738047 pooled germ cell tumors .f 2396 to 2882 511 to 28   AAA   484/484
(100 %)
3 diff
(99.4 %id)
BE502073 malignant melanoma, metastatic to lymphnode, skin .f 2400 to 2877 480 to 1       480/480
(100 %)
3 diff
(99.4 %id)
DB566193 hypothalamus .f 2414 to 2881 1 to 468     Submitted on the opposite strand 468/468
(100 %)
4 diff
(99.2 %id)
BU731758 eye, RPE and Choroid .f 2417 to 2882 484 to 19   AAA   466/475
(98 %)
2 diff
(99.6 %id)
AA700013 liver and spleen .f 2425 to 2882 455 to 1       455/455
(100 %)
7 diff
(98.5 %id)
DB564888 hypothalamus .f 2426 to 2881 1 to 456     Submitted on the opposite strand 456/456
(100 %)
4 diff
(99.2 %id)
BX331409 Neuroblastoma Cot 10-normalized .f 2435 to 2883 1 to 449   fully sequenced,   449/449
(100 %)
2 diff
(99.6 %id)
BE889852 leiomyosarcoma, uterus .f 2446 to 2881 1 to 437       437/437
(100 %)
11 diff
(97.5 %id)
DB544720 hippocampus .f 2449 to 2881 1 to 433     Submitted on the opposite strand 433/433
(100 %)
3 diff
(99.4 %id)
BQ672746 epidermoid carcinoma, cell line, salivary gland .f 2457 to 2617 1 to 161       161/165
(97 %)
1 diff
(99.4 %id)
AA759011   .f 2460 to 2883 427 to 6       422/427
(98 %)
0 diff
(100 %id)
BQ441762 epithelioid carcinoma, Pancreas .f 2464 to 2619 1 to 156       156/156
(100 %)
0 diff
(100 %id)
BP397878 pancreatic islet .f 2476 to 2882 1 to 407     Submitted on the opposite strand 407/407
(100 %)
4 diff
(99.1 %id)
BU687541 lung .f 2479 to 2882 422 to 19   AAA   404/404
(100 %)
2 diff
(99.6 %id)
BX393499 Neuroblastoma Cot 10-normalized .f 2480 to 2863 384 to 1   fully sequenced,   384/384
(100 %)
0 diff
(100 %id)
AI890594 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 2480 to 2878 400 to 2       399/401
(99 %)
0 diff
(100 %id)
AI148268 senescent fibroblast .f 2483 to 2877 404 to 11   AAA   394/394
(100 %)
8 diff
(98.0 %id)
AI587531 adenocarcinoma, Pancreas .f 2487 to 2883 401 to 6       396/401
(98 %)
0 diff
(100 %id)
BM694942 eye, RPE and Choroid .f 2497 to 2572 1 to 76   fully sequenced,   76/76
(100 %)
1 diff
(98.7 %id)
T15960   .f 2503 to 2882 380 to 1       380/380
(100 %)
2 diff
(99.5 %id)
AA830722 germinal center B cell .f 2504 to 2778 272 to 1       272/272
(100 %)
3 diff
(98.9 %id)
AI298775 carcinoid, lung .f 2508 to 2877 369 to 1       369/369
(100 %)
2 diff
(99.5 %id)
AU149319.
matches multiple genes
  .f 2511 to 2882 372 to 1     also hits gene DARS2 372/372
(100 %)
3 diff
(99.2 %id)
BM988255 mixed .f 2520 to 2877 376 to 19   AAA   358/358
(100 %)
4 diff
(98.9 %id)
F31030 pectoral muscle (after mastectomy) .f 2521 to 2654 1 to 134       134/134
(100 %)
0 diff
(100 %id)
AI200417 lung .f 2525 to 2883 358 to 2       357/359
(99 %)
0 diff
(100 %id)
AI798469 ovary, tumor, 5 pooled (see description) .f 2530 to 2883 353 to 1       353/353
(100 %)
3 diff
(99.2 %id)
AI825338 pooled germ cell tumors .f 2532 to 2883 355 to 4       352/355
(99 %)
0 diff
(100 %id)
AI809308 B-cell, chronic lymphotic leukemia .f 2532 to 2882 371 to 22   AAA   350/350
(100 %)
5 diff
(98.6 %id)
AI436070 pooled .f 2538 to 2877 353 to 14   AAA   340/340
(100 %)
11 diff
(96.8 %id)
CB051893 leiomyosarcoma, soft tissue .f 2542 to 2877 412 to 77   AAA   336/337
(99 %)
24 diff
(92.9 %id)
BU731735 eye, RPE and Choroid .f 2542 to 2881 358 to 19   fully sequenced, AAA   340/340
(100 %)
1 diff
(99.8 %id)
AW137267   .f 2547 to 2877 348 to 18   AAA   331/331
(100 %)
0 diff
(100 %id)
BQ027438 mixed .f 2552 to 2882 349 to 19   AAA   331/331
(100 %)
2 diff
(99.4 %id)
AA838214 epithelium (cell line), Prostate .f 2553 to 2883 366 to 38   AAA   329/329
(100 %)
8 diff
(97.6 %id)
AI344370 2 pooled tumors (clear cell type), Kidney .f 2553 to 2883 334 to 3       332/334
(99 %)
0 diff
(100 %id)
BG178921 adenocarcinoma, cell line, Prostate .f 2553 to 2877 1 to 325   AAA   325/325
(100 %)
2 diff
(99.4 %id)
AA838498 colon, colon tumor .f 2555 to 2883 358 to 32       327/358
(91 %)
0 diff
(100 %id)
AI085034 liver and spleen .f 2555 to 2882 327 to 1       327/327
(100 %)
2 diff
(99.4 %id)
EC536253 Prostate .f 2556 to 2682 1 to 127       127/127
(100 %)
2 diff
(98.5 %id)
AI537302 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 2558 to 2882 337 to 15   AAA   323/323
(100 %)
9 diff
(97.3 %id)
AI040364 liver and spleen .f 2561 to 2882 322 to 1       322/322
(100 %)
2 diff
(99.4 %id)
AI341279 pooled germ cell tumors .f 2571 to 2883 316 to 5       312/316
(98 %)
0 diff
(100 %id)
BC010873 Lung, large cell carcinoma .f 2575 to 2882 1 to 308   available from MGC, AAA   308/308
(100 %)
1 diff
(99.7 %id)
AI365563 B-cell, chronic lymphotic leukemia .f 2577 to 2877 300 to 1       300/300
(100 %)
13 diff
(95.7 %id)
BP395372 pancreatic islet .f 2592 to 2857 1 to 267     Submitted on the opposite strand 267/268
(99 %)
3 diff
(98.9 %id)
H78131 liver and spleen .f 2603 to 2858 256 to 1       256/256
(100 %)
3 diff
(98.9 %id)
AW082916 colon, moderately differentiated adenocarcinoma .f 2615 to 2882 292 to 23   AAA   270/270
(100 %)
5 diff
(98.2 %id)
BG171023 hypernephroma, cell line, Kidney .f 2616 to 2882 1 to 267   AAA   267/267
(100 %)
0 diff
(100 %id)
AI248063 liver and spleen .f 2617 to 2882 275 to 11   AAA   265/265
(100 %)
2 diff
(99.3 %id)
BX392246 Neuroblastoma Cot 25-normalized .f 2621 to 2872 249 to 1       249/254
(98 %)
8 diff
(96.9 %id)
AW337164 adenocarcinoma, Pancreas .f 2622 to 2882 276 to 16   AAA   261/261
(100 %)
6 diff
(97.8 %id)
AA683570 uterus .f 2623 to 2875 253 to 1       253/253
(100 %)
0 diff
(100 %id)
AW663937 pooled .f 2623 to 2882 272 to 13   AAA   260/260
(100 %)
5 diff
(98.1 %id)
AI357177 lymph node, lymphoma, follicular mixed small and largecell .f 2627 to 2882 282 to 27   AAA   256/256
(100 %)
7 diff
(97.3 %id)
AI927184 Kidney .f 2627 to 2882 267 to 11   AAA   257/257
(100 %)
5 diff
(98.1 %id)
AW473394 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 2627 to 2882 256 to 1       256/256
(100 %)
3 diff
(98.9 %id)
BF055078 pooled .f 2627 to 2877 264 to 14   AAA   251/251
(100 %)
7 diff
(97.3 %id)
EC560355 Prostate .f 2630 to 2736 1 to 108       108/108
(100 %)
2 diff
(98.2 %id)
AI991231 colon, colonic mucosa from 3 patients with Crohn'sdisease .f 2630 to 2880 257 to 7       251/257
(97 %)
0 diff
(100 %id)
BE644792 pooled .f 2630 to 2877 248 to 1       248/248
(100 %)
1 diff
(99.6 %id)
AA573353 colon .f 2631 to 2882 283 to 32   AAA   252/252
(100 %)
5 diff
(98.1 %id)
BX372963 Neuroblastoma Cot 50-normalized .f 2632 to 2900 271 to 1   fully sequenced,   271/271
(100 %)
14 diff
(94.9 %id)
AI500302 anaplastic oligodendroglioma, brain .f 2632 to 2883 253 to 2       252/259
(97 %)
0 diff
(100 %id)
AA365119 pineal body .f 2633 to 2837 1 to 205       205/206
(99 %)
2 diff
(99.1 %id)
BU623536 cell lines, Enchondroma .f 2634 to 2882 267 to 19   AAA   249/249
(100 %)
0 diff
(100 %id)
BM976459 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 2635 to 2882 266 to 19   AAA   248/248
(100 %)
5 diff
(98.0 %id)
AW872754 squamous cell carcinoma, tongue .f 2637 to 2882 265 to 20   AAA   246/246
(100 %)
4 diff
(98.4 %id)
BU623686 cell lines, Enchondroma .f 2637 to 2882 264 to 19   AAA   246/246
(100 %)
1 diff
(99.6 %id)
AI766544 colon, colon tumor, RER+ .f 2639 to 2882 244 to 1       244/244
(100 %)
0 diff
(100 %id)
AW589264 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 2645 to 2882 257 to 20   AAA   238/238
(100 %)
5 diff
(97.9 %id)
BQ549667 insulinoma, Pancreas .f 2645 to 2853 216 to 8       209/216
(96 %)
0 diff
(100 %id)
T32118 brain .f 2648 to 2881 234 to 1       234/234
(100 %)
0 diff
(100 %id)
AA719102 pineal gland .f 2654 to 2882 247 to 19   AAA   229/229
(100 %)
0 diff
(100 %id)
BF591154 colon, colon tumor, RER+ .f 2659 to 2860 146 to 347     Submitted on the opposite strand 202/347
(58 %)
6 diff
(98.3 %id)
AI370730   .f 2669 to 2882 214 to 1       214/214
(100 %)
0 diff
(100 %id)
AI469218 colon, moderately-differentiated adenocarcinoma .f 2673 to 2882 232 to 23   AAA   210/210
(100 %)
1 diff
(99.6 %id)
AI668957 Prostate .f 2676 to 2882 234 to 28   AAA   207/207
(100 %)
10 diff
(95.2 %id)
CA337187 posterior rhombomeres 5-8 (4 pooled) .f 2679 to 2877 1 to 199   AAA   199/199
(100 %)
0 diff
(100 %id)
BE888732 leiomyosarcoma, uterus .f 2695 to 2808 497 to 616       572/665
(86 %)
25 diff
(96.3 %id)
AI263592   .f 2712 to 2882 186 to 16   AAA   171/171
(100 %)
3 diff
(98.3 %id)
BX372931 Neuroblastoma Cot 50-normalized .f 2734 to 2881 152 to 1   fully sequenced,   152/152
(100 %)
3 diff
(98.1 %id)
AW167738 cervix .f 2760 to 2882 141 to 19   AAA   123/123
(100 %)
4 diff
(96.8 %id)
EC557230 Prostate .f 2769 to 2868 118 to 17       102/118
(86 %)
0 diff
(100 %id)
AW103958 ovary, tumor, 5 pooled (see description) .f 2769 to 2883 119 to 5       115/122
(94 %)
0 diff
(100 %id)
AA434441 ovarian tumor, ovary .f 2770 to 2882 113 to 1       113/113
(100 %)
0 diff
(100 %id)
EC502332 Prostate .f 2779 to 2878 102 to 4       99/102
(97 %)
0 diff
(100 %id)
BP196718 adrenal gland .g 1 to 576 2 to 577   tiling clone,   577/582
(99 %)
1 diff
(99.9 %id)
AK124341 uterus .g 19 to 2513 1 to 2495 exact tiling clone, available from FLJ,   2495/2495
(100 %)
6 diff
(99.8 %id)
DB251171 uterus .g 20 to 475 2 to 458   capped   457/457
(100 %)
1 diff
(99.8 %id)
BF952138 nervous_normal .g 695 to 1101 31 to 434   tiling clone,   404/446
(90 %)
6 diff
(98.7 %id)
BM701874 eye, optic nerve .g 1678 to 1822 1 to 144       144/144
(100 %)
3 diff
(98.0 %id)
BM671039 eye, optic nerve .g 1861 to 2513 672 to 19   tiling clone, AAA   654/654
(100 %)
3 diff
(99.6 %id)
DB351109 uterus .g 1971 to 2513 543 to 1       543/543
(100 %)
2 diff
(99.7 %id)
BM511087 insulinoma, Pancreas .h 1 to 458 1 to 459 K2R L86P S87Q V88R V89G ... tiling clone, fully sequenced,   459/459
(100 %)
4 diff
(99.2 %id)
BM512242 insulinoma, Pancreas .h 1 to 456 1 to 456 K2R V66L R68X     456/456
(100 %)
8 diff
(98.3 %id)
BQ581430 insulinoma, Pancreas .h 1 to 451 1 to 452 K2R L86P S87Q V88R V89G ... fully sequenced,   452/452
(100 %)
4 diff
(99.2 %id)
BU580099 insulinoma, Pancreas .h 1 to 482 1 to 482 K2R tiling clone, fully sequenced,   482/482
(100 %)
3 diff
(99.4 %id)
BQ335961 marrow .h 41 to 344 1 to 305       305/406
(75 %)
7 diff
(98.3 %id)
BQ549538 insulinoma, Pancreas .h 421 to 910 491 to 1   fully sequenced,   491/491
(100 %)
3 diff
(99.4 %id)
BM510835 insulinoma, Pancreas .h 428 to 910 484 to 1   tiling clone, fully sequenced,   484/484
(100 %)
3 diff
(99.4 %id)
BU579850 insulinoma, Pancreas .h 452 to 910 459 to 1   tiling clone, fully sequenced,   459/459
(100 %)
2 diff
(99.6 %id)
BM512002 insulinoma, Pancreas .h 672 to 906 274 to 40       235/274
(85 %)
0 diff
(100 %id)
DB258865 uterus .i 1 to 545 2 to 546   tiling clone, capped   545/545
(100 %)
1 diff
(99.9 %id)
BM836903 Ascites, stomach .i 42 to 553 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
BM832546 stomach .i 42 to 521 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
DA178539 amygdala .i 43 to 596 2 to 555 exact capped   554/554
(100 %)
0 diff
(100 %id)
DA278568 corpus callosum .i 43 to 583 2 to 543 exact capped   542/542
(100 %)
3 diff
(99.5 %id)
DA332172 hippocampus .i 43 to 607 2 to 569 exact capped   568/568
(100 %)
3 diff
(99.5 %id)
DA351882 substantia nigra .i 43 to 590 2 to 554 exact capped   553/553
(100 %)
7 diff
(98.8 %id)
DA528169 brain .i 43 to 647 2 to 606 exact tiling clone, capped   605/605
(100 %)
0 diff
(100 %id)
DA761738 tongue .i 43 to 577 2 to 538 exact capped   537/537
(100 %)
2 diff
(99.7 %id)
DA959233 Spleen .i 43 to 605 2 to 567 exact capped   566/566
(100 %)
3 diff
(99.5 %id)
DB007829 cervix, tumor tissue .i 43 to 614 2 to 576 exact capped   575/575
(100 %)
3 diff
(99.5 %id)
DB261825 uterus .i 43 to 530 2 to 492   capped   491/491
(100 %)
3 diff
(99.4 %id)
DB266144 uterus .i 43 to 537 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DA037515   .i 45 to 593 2 to 550 exact capped   549/549
(100 %)
0 diff
(100 %id)
DA394673 thalamus .i 52 to 577 2 to 529 exact capped   528/528
(100 %)
2 diff
(99.7 %id)
DA773441 brain .i 52 to 605 2 to 557 exact capped   556/556
(100 %)
2 diff
(99.7 %id)
DA962507 stomach .i 52 to 580 2 to 531 exact capped   530/530
(100 %)
1 diff
(99.9 %id)
BP297126   .j 1 to 580 2 to 581 exact tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
CN427505 embryonic stem cells, DMSO-treated H9 cellline .j 6 to 632 1 to 627 exact tiling clone,   627/627
(100 %)
4 diff
(99.4 %id)
DA935057 Spleen .k 1 to 481 2 to 482 S59T tiling clone, capped   481/481
(100 %)
2 diff
(99.6 %id)
AK308520 bladder Gene C20orf27, variant not shown         Suspected internal deletion, this clone was ignored    
DA045232 bladder Gene C20orf27, variant not shown       capped Suspected internal deletion, this clone was ignored    
BP341075 stomach mucosa Gene C20orf27, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI